首页> 外文会议>IEEE International Conference on Nano/Molecular Medicine and Engineering >Imaging and Mapping Individual Target Proteins on Clinical Lymphoma Cells by AFM
【24h】

Imaging and Mapping Individual Target Proteins on Clinical Lymphoma Cells by AFM

机译:通过AFM成像和映射临床淋巴瘤细胞上的个体靶蛋白

获取原文

摘要

The wide applications of atomic force microscopy (AFM) in the past decade have contributed much to the field of cell biology, providing a lot of novel insights into cellular behaviors at the nanoscale. However, current AFM studies are commonly performed on cell lines cultured in vitro which are quite different from the cells in the human body. Directly investigating the physiological activities on tumor cells from clinical patients is of great significance for helping us to better understand the actual cellular activities taking place in the clinical environment. Under the fluorescence recognition of specific tumor cell surface marker, we have used AFM to investigate the binding affinity and nanoscale distributions of CD20 target protein directly on tumor cells prepared from the bone marrow of lymphoma patients. The results provide a new idea to develop closer links between laboratory study and clinical practice, which may have potential impacts on diverse fields such as drug evaluation and efficacy prediction.
机译:过去十年的原子力显微镜(AFM)的广泛应用为细胞生物学领域提供了很多影响,为纳米级的细胞行为提供了大量的新洞察力。然而,通常对在体外培养的细胞系上进行当前的AFM研究,这与人体中的细胞完全不同。直接研究来自临床患者的肿瘤细胞的生理活性具有重要意义,帮助我们更好地了解临床环境中发生的实际细胞活动。在特定肿瘤细胞表面标记的荧光识别下,我们使用AFM直接研究CD20靶蛋白的结合亲和力和纳米级分布在淋巴瘤患者骨髓骨髓中的肿瘤细胞上。结果提供了一种新的想法,可以在实验室研究和临床实践之间制定更紧密的联系,这可能对不同的领域产生潜在的影响,例如药物评估和功效预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号